Read More Pharma Industry News Why industry observers are watching Tenvie Therapeutics’ TNV262 biomarker readout in 2026 Tenvie Therapeutics’ TNV262 readout in 2026 could reshape obesity and cardiometabolic drug development. Read why markets are watching closely. bySoujanya RaviApril 9, 2026